Acuamark Dx
New York, US · 1 known investors
Find your way into Acuamark Dx
35 people in our graph share verified history with the Acuamark Dx team — schools, employers, funds. One of them is your warm intro.
Dan Malvenunlockedknows Bernard Peperstraete · together at Kauffman Fellows (overlapped)
×10knows the team · via Kauffman Fellows
knows the team · via Tan Tock Seng Hospital Pte Ltd
AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.
Founders & leadership
BP

Bernard Peperstraetein𝕏Co-Founder and CEOBernard Peperstraete is co-founder and CEO of Acuamark Dx, a molecular diagnostics company developing blood-based cancer detection technology. He previously led ACT Biotech, a cancer pharmaceutical company acquired by Eddingpharm, and spent nearly a decade in healthcare venture capital as a partner at NGN Capital, following earlier roles at Novartis, Bristol Myers & Squibb, and Tan Tock Seng Hospital in Singapore, with an MBA from Harvard and training in tropical medicine.
Investors · 1
Competitors · 1
by search overlapCompanies competing with Acuamark Dx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Acuamark Dx do?
- AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.
- Who founded Acuamark Dx?
- Acuamark Dx was founded by Bernard Peperstraete.
- Who are Acuamark Dx's investors?
- Acuamark Dx's investors include 1955 Capital.
- Where is Acuamark Dx headquartered?
- Acuamark Dx is headquartered in New York, US.



